Dexras2 inhibitors belong to a class of chemical compounds that have garnered attention in the fields of molecular biology due to modulating specific cellular processes. Dexras2, also known as Ras-related protein 10 (R-Ras2), is a member of the Ras superfamily of GTPases. This protein plays a role in intracellular signaling pathways, particularly those involved in cell growth, differentiation, and cytoskeletal dynamics. Dexras2 is a multifunctional protein that interacts with various signaling partners, making it a crucial regulator of cellular processes, including cell adhesion, migration, and synaptic plasticity. Dexras2 inhibitors are designed to interact with the active site or binding domain of the Dexras2 protein, effectively inhibiting its function and influencing cellular processes dependent on Dexras2-mediated signaling.
Structurally, Dexras2 inhibitors are engineered to selectively target the active site of Dexras2, ensuring high specificity for this particular GTPase. By inhibiting Dexras2, these compounds may disrupt its role in signaling cascades, leading to alterations in cellular processes such as cell adhesion, migration, and synaptic plasticity. The study of Dexras2 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions and their impact on various physiological processes. This knowledge contributes to our understanding of basic cell biology and may have implications in various research areas, including neuronal development, cancer biology, and neurobiology. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of Dexras2-mediated signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Similar to Sildenafil, could modulate NO signaling pathways, potentially impacting Dexras2 expression. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Another phosphodiesterase inhibitor, might influence Dexras2 expression through NO signaling modulation. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
An alpha-2 adrenergic receptor antagonist, might affect neuronal signaling pathways related to Dexras2 expression. | ||||||
Guanabenz HCl | 23113-43-1 | sc-507500 | 100 mg | $246.00 | ||
As an adrenergic agonist, could impact neurochemical pathways that regulate Dexras2 expression. | ||||||
Guanfacine | 29110-47-2 | sc-353618 | 200 mg | $1900.00 | ||
Similar to Guanabenz, might influence adrenergic signaling, potentially affecting Dexras2 expression. | ||||||
Clonidine | 4205-90-7 | sc-501519 | 100 mg | $240.00 | 1 | |
An alpha-2 adrenergic receptor agonist, could modulate neurochemical pathways influencing Dexras2. | ||||||
Rilmenidine | 54187-04-1 | sc-478251 | 50 mg | $190.00 | 1 | |
Another adrenergic agonist, might affect signaling pathways relevant to Dexras2 expression. | ||||||
Moxonidine | 75438-57-2 | sc-358375 | 1 g | $716.00 | ||
Impacts adrenergic and imidazoline receptors, potentially influencing Dexras2 expression. | ||||||